NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Funding > Funding Newsletter for Global Health Researchers > Funding news for global health researchers March 9, 2020 Print

COVID-19 is an emerging, rapidly evolving situation.


Funding news for global health researchers March 9, 2020

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.

  • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (PAR-20-111)
    Application Receipt Date(s): August 11, 2020, and more

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers.

  • Notice of Special Interest (NOSI): Mechanistic Investigations of Psychosocial Factors Associated with Substance Use Disorders (NOT-DA-20-005)
  • Notice of Special Interest (NOSI): Harnessing computational tools for sophisticated analyses of Substance Use Disorder-related behaviors (NOT-DA-20-017)
  • Notice of Special Interest (NOSI): Human Molecular Genetics of Substance Use Disorders (NOT-DA-20-030)
  • Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain (NOT-DA-20-039)

Funding News

NIH funding news that may be relevant to global health researchers.

  • Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) Exploratory/Developmental Research Projects (UH2 Cooperative Agreement, Clinical Trial Optional (NOT-AA-20-004)

Upcoming Deadlines